FDA Webinar: Building Confidence in Generic Narrow Therapeutic Index (NTI) Drugs, September 18, 2018
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, September 18, 2018, at 1:00PM (EDT), CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: Building Confidence in Generic Narrow Therapeutic Index (NTI) Drugs. This webinar will introduce the general characteristics of Narrow Therapeutic Index or NTI drugs and discuss FDA’s innovative approach and criteria for generic NTI drug equivalence evaluation. In addition, we will discuss results from a bioequivalence study comparing brand and generic tacrolimus (an NTI drug) capsules in stable transplant patients to address patients’ and health practitioners’ questions regarding substitutability of generic immunosuppressant drugs.
